Click to copy
Click to copy

Concert: 2Q Earnings Snapshot

August 1, 2019

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $18.7 million in its second quarter.

On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 78 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.

The biopharmaceutical company posted revenue of $49,000 in the period.

Concert shares have fallen 20% since the beginning of the year. The stock has decreased 37% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE

All contents © copyright 2019 The Associated Press. All rights reserved.